eClinical Solutions Market by Products (CDMS/EDC, CTMS, Ecoa , Randomization & Trial Supply Management, Safety), Services, Buyers (Pharma/Biopharma, CROS, Healthcare Providers) & Delivery Modes (Web Hosted, on-Premise, Cloud-Based)-Global Forecast to 2018 - WTOC-TV: Savannah, Beaufort, SC, News, Weather & Sports

eClinical Solutions Market by Products (CDMS/EDC, CTMS, Ecoa , Randomization & Trial Supply Management, Safety), Services, Buyers (Pharma/Biopharma, CROS, Healthcare Providers) & Delivery Modes (Web Hosted, on-Premise, Cloud-Based)-Global Forecast to 2018

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Reportlinker



 

NEW YORK, Feb. 19, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

eClinical Solutions Market by Products (CDMS/EDC, CTMS, Ecoa , Randomization & Trial Supply Management, Safety), Services, Buyers (Pharma/Biopharma, CROS, Healthcare Providers) & Delivery Modes (Web Hosted, on-Premise, Cloud-Based)-Global Forecast to 2018
http://www.reportlinker.com/p02006099/eClinical-Solutions-Market-by-Products-CDMS/EDC-CTMS-Ecoa--Randomization--Trial-Supply-Management-Safety-Services-Buyers-Pharma/Biopharma-CROS-Healthcare-Providers--Delivery-Modes-Web-Hosted-on-Premise-Cloud-Based-Global-Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

The global eClinical solutions market is estimated to grow at a CAGR of 13.5% and is expected to reach ~$5 billion by 2018. Compared to matured markets, the Asia-Pacific region is expected to grow at the highest CAGR of 19.5%. The growth of the eClinical solutions market is primarily triggered by factors such as, growth in the number of clinical trials, increasing government pressure to reduce the cost and time spent on clinical trials, government funding for conducting clinical research, and significant investment on research and development by pharmaceutical and biopharmaceutical companies for drug development. However, factors such as high cost of implementation of eClinical systems and scarcity of a skilled workforce for conducting clinical trials are restraining the growth of the eClinical solutions market.

In this market, various factors such as the increasing adoption of cloud computing technology for delivering eClinical solutions and rapid growth in clinical trial outsourcing to CROs (clinical research organizations) based in developing countries such as China, South Korea, and India are presenting new growth opportunities for eClinical solution vendors. Moreover, companies are increasingly adopting the strategy of integrating two or more eClinical systems, to strengthen their footprint in the global eClinical solutions market.

In this report, the global eClinical solutions market is broadly segmented into two categories, namely, products and professional services. The products market is further classified into clinical data management systems (CDMS)/electronic data capture (EDC), clinical trial management systems (CTMS), electronic clinical outcome assessment (eCOA), randomization and trial supply management (RTSM), safety solutions, and others. The others segment includes core lab integration systems, regulatory information management services, and coding systems. The professional services segment includes implementation services, training, support services, and consulting. The products market held the largest share of the global eClinical solutions market and is poised to grow at a CAGR of 13.8% in the forecast period. Factors such as the growing need for data standardization to meet regulatory requirements, rising demand for site and data collection solutions, launch of new eClinical systems, and increasing acceptance of ePRO (electronic patient reported outcome) solutions (due to better work efficiency) are stimulating the growth of the eClinical products market.

North America (comprising the U.S., Canada, and Mexico) commanded the largest share of ~60.1% of the global eClinical solutions market, followed by Europe (26.4%). A number of factors such as the presence of a well-developed infrastructure, large number of eClinical solution vendors as well as pharmaceutical and biopharmaceutical companies, and favorable reimbursement scenario are driving the growth of the eClinical solutions market in North America. However, high operating cost of conducting clinical trials, and stringent and lengthy regulatory requirements are the major restraining factors for the growth of the eClinical solutions market in North America. The Asia-Pacific region is poised to grow at the highest CAGR of 19.5% in the next five years. The growth of eClinical solutions in the Asia-Pacific market is propelled by factors such as lower cost of conducting clinical trials, increasing clinical trial outsourcing to CROs based in developing economies, and presence of a large patient population in the Asia-Pacific region.

The global eClinical solutions market is highly competitive with a large number of global as well as local market players. As of 2012, the global eClinical solutions market was dominated by Oracle Corporation (U.S.), PAREXEL International Corporation (U.S.), BioClinica, Inc. (U.S.), DATATRAK International, Inc. (U.S.), Medidata Solutions, Inc. (U.S.), PHT Corporation (U.S.), eResearch Technology (U.S.), Merge Healthcare Incorporated (U.S.), and OmniComm Systems, Inc. (U.S). Partnerships, agreements, collaborations, and joint ventures were the key strategies adopted by market players, to strengthen their presence in the market. Along with these strategies, companies in this market also adopted new product launches, product development, and mergers and acquisitions, to strengthen their product portfolio and expand their geographic presence.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as, market share analysis, market segmentation on the basis of products, professional services, type of buyer, delivery mode, geographic analysis, and company profiles, which together comprise and discuss basic views on competitive landscape, emerging and high growth segments of the eClinical solutions market, high growth regions and their respective regulatory policies, government initiatives, restraints, drivers, and opportunities. The above mentioned market research data, current market size, and forecast of future trends will help existing players and new entrants to make necessary decisions regarding product offerings, geographic focus, change in strategic approach, R&D investment for innovation in products and technologies, and levels of output, in order to remain successful.

Firms purchasing this report could use any one or combination of the following strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for reaping market share.

The report provides insights on the following pointers:

• Comprehensive information on product and professional services offered by top players in the global eClinical solutions market. The report analyzes the product and professional services market by type of buyer/delivery modes across geographies -Market Penetration

• Detailed insights on upcoming technologies, research and development activities, and new product launches in the eClinical solutions market - Product Development/Innovation

• Comprehensive information about lucrative emerging markets. The report analyzes markets for various eClinical solutions products and professional services across geographies - Market Development

• Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the eClinical solutions market - Market Diversification

• In-depth assessment of market share, products and services, distribution networks, and manufacturing capabilities of leading players in the global eClinical solutions market - Competitive Assessment

1 INTRODUCTION 19

1.1 KEY TAKE-AWAYS 19
1.2 REPORT DESCRIPTION 19
1.3 MARKETS COVERED 21
1.4 STAKEHOLDERS 22
1.5 MARKET SCOPE 22
1.6 RESEARCH METHODOLOGY 22
1.6.1 MARKET SIZE ESTIMATION 25
1.6.2 MARKET CRACKDOWN & DATA TRIANGULATION 27
1.6.3 MARKET SHARE ESTIMATION 27
1.6.4 KEY DATA POINTS FROM SECONDARY SOURCES 27
1.6.5 KEY DATA POINTS FROM PRIMARY SOURCES 28
1.6.6 ASSUMPTIONS 28

2 EXECUTIVE SUMMARY 30

3 MARKET OVERVIEW 34

3.1 INTRODUCTION 35
3.1.1 CLINICAL TRIALS DEFINITION 35
3.1.2 CLINICAL TRIALS PROCESS 35
3.1.3 eCLINICAL SOLUTIONS DEFINITION 38
3.2 eCLINICAL PROCESS & eCLINICAL PLATFORM 39
3.3 MARKET SEGMENTATION 40
3.3.1 eCLINICAL SOLUTIONS MARKET, BY PRODUCT 41
3.3.2 eCLINICAL SOLUTIONS MARKET, BY SERVICE 42
3.3.3 eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER 43
3.3.4 eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 44
3.4 MARKET DYNAMICS 45
3.4.1 DRIVERS 46
3.4.1.1 Need to reduce the cost and time consumed in clinical trial processes is driving the adoption of eClinical trial solutions 46
3.4.1.2 Need for improved data standardization is increasing the adoption of IT Solutions 46
3.4.1.3 Government grants to support clinical trials are enhancing the growth of the market 47
3.4.1.4 Upgradation of solutions are enhancing the applications of eClinical solutions 48
3.4.1.5 Heavy clinical R&D expenditure by the pharmaceutical industry is driving the market growth 49
3.4.2 RESTRAINTS 50
3.4.2.1 Burden on clinical research teams in terms of skill levels required and training 50
3.4.2.2 High cost of eClinical systems restricts the user count 50
3.4.3 CHALLENGES 51
3.4.3.1 Complexity of system architecture 51
3.4.3.2 Low adoption rate of eClinical solutions 51
3.4.4 OPPORTUNITIES 51
3.4.4.1 Increasing clinical research in Asian countries 51
3.4.4.2 Development of cost-effective modules 52
3.4.4.3 Cloud technology facilitates an increase in clinical research globally 52
3.4.4.4 Shift of clinical trials and resources from AMCs to CROs in the past decade 52
3.5 WINNING IMPERATIVES 53
3.5.1 INTEGRATION OF eCLINICAL SOLUTIONS 53

4 eCLINICAL SOLUTIONS MARKET, BY PRODUCT 54

4.1 INTRODUCTION 55
4.2 CLINICAL DATA MANAGEMENT SYSTEM (CDMS)/ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS MARKET 58
4.3 CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) SOLUTIONS MARKET 60
4.4 ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA) SOLUTIONS MARKET 63
4.4.1 INTERACTIVE VOICE RESPONSE SYSTEM (IVRS) 63
4.4.2 INTERACTIVE WEB RESPONSE SYSTEM (IWR) 63
4.4.3 HANDHELD DEVICES, TABLETS, & PDAS 63
4.4.4 DIGITAL PENS (DP SYSTEM) 64
4.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM) SOLUTIONS MARKET 66
4.6 SAFETY SOLUTIONS MARKET 67
4.7 OTHERS 69

5 eCLINICAL SOLUTIONS MARKET, BY PROFESSIONAL SERVICES 71

5.1 INTRODUCTION 72
5.2 IMPLEMENTATION SERVICES MARKET 75
5.3 TRAINING SERVICES MARKET 77
5.4 SUPPORT SERVICES MARKET 79
5.5 CONSULTING SERVICES MARKET 80

6 GLOBAL eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER 82

6.1 INTRODUCTION 83
6.2 PHARMACEUTICAL/BIOPHARMACEUTICAL/MEDICAL DEVICE COMPANIES 85
6.3 CLINICAL RESEARCH ORGANIZATIONS (CROs) 87
6.4 HEALTHCARE PROVIDERS 89

7 eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 91

7.1 INTRODUCTION 92
7.2 WEB-HOSTED (ON-DEMAND) DELIVERY MODE 94
7.3 LICENSED ENTERPRISE (ON-PREMISE) SOLUTIONS 96
7.4 CLOUD-BASED (SAAS) DELIVERY MODE 98

8 GEOGRAPHIC ANALYSIS 100

8.1 INTRODUCTION 101
8.1.1 eCLINICAL SOLUTIONS MARKET: GEOGRAPHIC ANALYSIS 102
8.2 NORTH AMERICA 103
8.2.1 U.S. 109
8.2.2 CANADA 110
8.3 EUROPE 111
8.3.1 GERMANY 116
8.3.2 UNITED KINGDOM 117
8.3.3 FRANCE 118
8.4 ASIA-PACIFIC 119
8.4.1 INDIA 125
8.4.2 CHINA 127
8.4.3 JAPAN 128
8.5 REST OF THE WORLD (ROW) 129
8.5.1 LATIN AMERICA 134
8.5.2 MIDDLE EAST 135
8.5.3 AFRICA 136

9 COMPETITIVE LANDSCAPE 137

9.1 OVERVIEW 137
9.2 MARKET SHARE ANALYSIS, BY SEGMENT AND KEY PLAYERS 137
9.2.1 KEY PLAYERS IN THE CLINICAL DATA MANAGEMENT SYSTEM (CDMS)/ELECTRONIC DATA CAPTURE (EDC) SOLUTIONS MARKET 137
9.2.2 KEY PLAYERS IN THE CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS) SOLUTIONS MARKET 139
9.2.3 KEY PLAYERS IN THE ELECTRONIC CLINICAL OUTCOMES ASSESMENT (ECOA) SOLUTIONS MARKET 142
9.3 COMPETITIVE SITUATION AND TRENDS 143
9.3.1 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES 145
9.3.2 NEW PRODUCT LAUNCH AND PRODUCT DEVELOPMENT 158
9.3.3 MERGERS AND ACQUISITIONS 165
9.3.4 OTHER DEVELOPMENTS 167

10 COMPANY PROFILES 170
(Overview, Financials, Products & Services, Strategy, & Developments)*


10.1 BIOCLINICA, INC. 170
10.2 CRF HEALTH 179
10.3 DATATRAK INTERNATIONAL, INC. 184
10.4 ERESEARCH TECHNOLOGY, INC. 193
10.5 MEDIDATA SOLUTIONS, INC. 199
10.6 MERGE HEALTHCARE INCORPORATED 209
10.7 OMNICOMM SYSTEMS, INC. 216
10.8 ORACLE CORPORATION 224
10.9 PAREXEL INTERNATIONAL CORP. 232
10.10 PHT CORPORATION 244
*Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.

LIST OF TABLES

TABLE 1 GLOBAL eCLINICAL SOLUTIONS MARKET, BY TYPE,
2011–2018 ($MILLION) 30
TABLE 2 eCLINICAL SOLUTIONS MARKET, BY PRODUCT,
2011–2018 ($MILLION) 56
TABLE 3 eCLINICAL SOLUTION PRODUCTS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 57
TABLE 4 CDMS/EDC SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 59
TABLE 5 CTMS SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 62
TABLE 6 eCOA SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 65
TABLE 7 RTSM SYSTEMS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 67
TABLE 8 SAFETY SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 68
TABLE 9 OTHER eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 69
TABLE 10 GLOBAL eCLINICAL SOLUTIONS MARKET, BY PROFESSIONAL SERVICES, 2011–2018 ($MILLION) 73
TABLE 11 GLOBAL eCLINICAL SOLUTIONS PROFESSIONAL SERVICES MARKET,
BY GEOGRAPHY, 2013–2018 ($MILLION) 74
TABLE 12 IMPLEMENTATION SERVICES MARKET, BY GEOGRAPHY,
2013–2018 ($MILLION) 76
TABLE 13 TRAINING SERVICES MARKET, BY GEOGRAPHY,
2013–2018 ($MILLION) 78
TABLE 14 SUPPORT SERVICES MARKET, BY GEOGRAPHY,
2013–2018 ($MILLION) 79
TABLE 15 CONSULTING SERVICES MARKET, BY GEOGRAPHY,
2013–2018 ($MILLION) 81
TABLE 16 GLOBAL eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER,
2011–2018 ($MILLION) 84
TABLE 17 PHARMACEUTICAL/BIOPHARMACEUTICAL/MEDICAL DEVICE COMPANIES eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 86
TABLE 18 CROs eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 88
TABLE 19 HEALTHCARE PROVIDERS eCLINICAL SOLUTIONS MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 89
TABLE 20 eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE,
2011–2018 ($MILLION) 93
TABLE 21 WEB-BASED eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 95
TABLE 22 ON-PREMISE MODEL BASED eCLINICAL SOLUTIONS MARKET,
BY GEOGRAPHY, 2011–2018 ($MILLION) 97
TABLE 23 CLOUD-BASED eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2011–2018 ($MILLION) 99
TABLE 24 GLOBAL eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2013–2018 ($MILLION) 102
TABLE 25 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET,
BY PRODUCTS AND SERVICES, 2013–2018 ($MILLION) 104
TABLE 26 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET, BY PRODUCT, 2013–2018 ($MILLION) 105
TABLE 27 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET,
BY PROFESSIONAL SERVICE, 2013–2018 ($MILLION) 106
TABLE 28 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER, 2013–2018 ($MILLION) 107
TABLE 29 NORTH AMERICA: eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2013–2018 ($MILLION) 108
TABLE 30 EUROPE: eCLINICAL SOLUTIONS MARKET, BY PRODUCTS
AND SERVICES, 2013–2018 ($MILLION) 111
TABLE 31 EUROPE: eCLINICAL SOLUTIONS MARKET, BY PRODUCT,
2013–2018 ($MILLION) 112
TABLE 32 EUROPE: eCLINICAL SOLUTIONS MARKET, BY PROFESSIONAL SERVICE, 2013–2018 ($MILLION) 113
TABLE 33 EUROPE: eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER,
2013–2018 ($MILLION) 114
TABLE 34 EUROPE: eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE,
2013–2018 ($MILLION) 115
TABLE 35 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET, BY PRODUCTS
AND SERVICES, 2013–2018 ($MILLION) 120
TABLE 36 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET, BY PRODUCT,
2013–2018 ($MILLION) 121
TABLE 37 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET, BY PROFESSIONAL SERVICES, 2013–2018 ($MILLION) 122
TABLE 38 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER, 2013–2018 ($MILLION) 123
TABLE 39 ASIA-PACIFIC: eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2013–2018 ($MILLION) 124
TABLE 40 ROW: eCLINICAL SOLUTIONS MARKET, BY PRODUCTS AND SERVICES, 2013–2018 ($MILLION) 129
TABLE 41 ROW: eCLINICAL SOLUTIONS MARKET, BY PRODUCT,
2013–2018 ($MILLION) 130
TABLE 42 ROW: eCLINICAL SOLUTIONS MARKET, BY PROFESSIONAL SERVICE, 2013–2018 ($MILLION) 131
TABLE 43 ROW: eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER,
2013–2018 ($MILLION) 132
TABLE 44 ROW: eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE,
2013–2018 ($MILLION) 133
TABLE 45 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS,
AND JOINT VENTURES, 2011–2013 145
TABLE 46 NEW PRODUCT LAUNCH AND PRODUCT DEVELOPMENT,
2011–2013 159
TABLE 47 MERGERS & ACQUISITIONS, 2011–2013 165
TABLE 48 OTHER DEVELOPMENTS, 2011–2013 167
TABLE 49 BIOCLINICA, INC.: TOTAL REVENUE, 2010–2012 ($MILLION) 171
TABLE 50 DATATRAK INTERNATIONAL, INC.: TOTAL REVENUE
AND R&D EXPENDITURE, 2010–2012 ($MILLION) 185
TABLE 51 ERESEARCH TECHNOLOGY, INC.: TOTAL REVENUE
AND R&D EXPENDITURE, 2009 – 2011 ($MILLION) 194
TABLE 52 MEDIDATA SOLUTIONS, INC.: TOTAL REVENUE,
2010 – 2012 ($MILLION) 200
TABLE 53 MERGE HEALTHCARE, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010–2012 ($MILLION) 210
TABLE 54 OMNICOMM SYSTEMS, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2010–2012 ($MILLION) 217
TABLE 55 ORACLE CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2011–2013 ($MILLION) 225
TABLE 56 PAREXEL INTERNATIONAL CORP.: TOTAL REVENUE
AND R&D EXPENDITURE, 2011 – 2013 ($MILLION) 233

LIST OF FIGURES

FIGURE 1 GLOBAL eCLINICAL SOLUTIONS MARKET: RESEARCH METHODOLOGY 23
FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY 26
FIGURE 3 GLOBAL eCLINICAL SOLUTIONS MARKET, BY SEGMENTS, 2013 31
FIGURE 4 GLOBAL eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY, 2013 32
FIGURE 5 CLINICAL TRIAL PROCESS 36
FIGURE 6 BENEFITS OF USING eCLINICAL SOLUTIONS IN CLINICAL TRIALS 39
FIGURE 7 eCLINICAL SOLUTIONS MARKET SEGMENTATION 40
FIGURE 8 eCLINICAL SOLUTIONS MARKET SEGMENTATION, BY PRODUCT 41
FIGURE 9 eCLINICAL SOLUTIONS MARKET SEGMENTATION, BY SERVICE 42
FIGURE 10 eCLINICAL SOLUTIONS MARKET SEGMENTATION, BY TYPE OF BUYER 43
FIGURE 11 eCLINICAL SOLUTIONS MARKET SEGMENTATION, BY DELIVERY MODE 44
FIGURE 12 MARKET DYNAMICS: GLOBAL eCLINICAL SOLUTIONS MARKET 45
FIGURE 13 IMPACT ANALYSIS: DRIVERS OF THE eCLINICAL SOLUTIONS MARKET 49
FIGURE 14 IMPACT ANALYSIS: RESTRAINTS OF THE eCLINICAL SOLUTIONS MARKET 50
FIGURE 15 GLOBAL eCLINICAL SOLUTIONS MARKET, BY PRODUCT,
2013 VS. 2018 55
FIGURE 16 BENEFITS OF EDC SYSTEM APPLICATIONS IN CLINICAL TRIALS 58
FIGURE 17 CTMS MODULES 61
FIGURE 18 GLOBAL eCLINICAL SOLUTIONS MARKET, BY PROFESSIONAL SERVICES, 2013 VS. 2018 72
FIGURE 19 GLOBAL eCLINICAL SOLUTIONS MARKET, BY TYPE OF BUYER,
2013 VS. 2018 83
FIGURE 20 GLOBAL eCLINICAL SOLUTIONS MARKET, BY DELIVERY MODE,
2013 VS. 2018 92
FIGURE 21 GLOBAL eCLINICAL SOLUTIONS MARKET, BY GEOGRAPHY,
2013–2018 ($MILLION) 101
FIGURE 22 GLOBAL CDMS/EDC SOLUTIONS MARKET SHARE, BY KEY PLAYERS, 2012 138
FIGURE 23 GLOBAL CTMS SOLUTIONS MARKET SHARE, BY KEY PLAYERS, 2012 140
FIGURE 24 GLOBAL ECOA SOLUTIONS MARKET, BY KEY PLAYERS, 2012 142
FIGURE 25 KEY GROWTH STRATEGIES, 2011–2013 144
FIGURE 26 BIOCLINICA, INC.: BUSINESS REVENUE MIX, 2012 171
FIGURE 27 BIOCLINICA, INC.: SERVICE SEGMENT, GEOGRAPHIC REVENUE MIX, 2012 172
FIGURE 28 BIOCLINICA, INC.: MAJOR STRATEGY, 2011–2013 174
FIGURE 29 CRF HEALTH: MAJOR STRATEGY, 2011–2013 181
FIGURE 30 DATATRAK INTERNATIONAL, INC.: MAJOR STRATEGY, 2011–2013 187
FIGURE 31 ERESEARCH TECHNOLOGY, INC.: BUSINESS REVENUE MIX, 2011 194
FIGURE 32 ERESEARCH TECHNOLOGY, INC.: GEOGRAPHIC REVENUE MIX, 2011 195
FIGURE 33 ERESEARCH TECHNOLOGY, INC.: MAJOR STRATEGY, 2011–2013 197
FIGURE 34 MEDIDATA SOLUTIONS, INC.: BUSINESS REVENUE MIX, 2012 200
FIGURE 35 MEDIDATA SOLUTIONS, INC.: GEOGRAPHIC REVENUE MIX, 2012 201
FIGURE 36 MEDIDATA SOLUTIONS, INC.: MAJOR STRATEGY, 2011–2013 203
FIGURE 37 MERGE HEALTHCARE, INC.: BUSINESS REVENUE MIX, 2012 210
FIGURE 38 MERGE HEALTHCARE, INC.: GEOGRAPHIC REVENUE MIX, 2012 211
FIGURE 39 MERGE HEALTHCARE, INC.: MAJOR STRATEGY, 2011–2013 213
FIGURE 40 OMNICOMM SYSTEMS, INC.: BUSINESS REVENUE MIX, 2012 217
FIGURE 41 OMNICOMM SYSTEMS, INC.: MAJOR STRATEGY, 2011–2013 219
FIGURE 42 ORACLE CORPORATION: BUSINESS REVENUE MIX, 2013 225
FIGURE 43 ORACLE CORPORATION: GEOGRAPHIC REVENUE MIX, 2013 226
FIGURE 44 ORACLE CORPORATION: MAJOR STRATEGY, 2011–2013 228
FIGURE 45 PAREXEL INTERNATIONAL CORP.: BUSINESS REVENUE MIX, 2013 233
FIGURE 46 PAREXEL INTERNATIONAL CORP.: GEOGRAPHIC REVENUE MIX, 2013 234
FIGURE 47 PAREXEL INTERNATIONAL CORPORATION: MAJOR STRATEGY,
2011–2013 237
FIGURE 48 PHT CORPORATION: MAJOR STRATEGY, 2011–2013 246


To order this report: eClinical Solutions Market by Products (CDMS/EDC, CTMS, Ecoa , Randomization & Trial Supply Management, Safety), Services, Buyers (Pharma/Biopharma, CROS, Healthcare Providers) & Delivery Modes (Web Hosted, on-Premise, Cloud-Based)-Global Forecast to 2018
http://www.reportlinker.com/p02006099/eClinical-Solutions-Market-by-Products-CDMS/EDC-CTMS-Ecoa--Randomization--Trial-Supply-Management-Safety-Services-Buyers-Pharma/Biopharma-CROS-Healthcare-Providers--Delivery-Modes-Web-Hosted-on-Premise-Cloud-Based-Global-Forecast-to-2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development



__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow